DONALD KLASING: Open Payments
NPI 1508860230 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 63 payments from 13 companies in 2025. Trend: 2023 $482 · 2024 $607 · 2025 $1,060
Food & beverage: $1,052Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $310 |
| Collegium Pharmaceutical, Inc. | 2 | $143 |
| Supernus Pharmaceuticals, Inc. | 20 | $128 |
| Vanda Pharmaceuticals Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Corium, LLC | 9 | $53 |
| ABBVIE INC. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Lundbeck LLC | 2 | $35 |
Products named: REXULTI, Jornay PM, ABILIFY MAINTENA, Qelbree, FANAPT, CAPLYTA, Azstarys, VRAYLAR.
Industry payments across AL — which companies pay providers there.
